Literature DB >> 26304234

MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.

Jia-Quan Qu1, Hong-Mei Yi1, Xu Ye1, Jin-Feng Zhu1, Hong Yi1, Li-Na Li1, Ta Xiao1, Li Yuan1, Jiao-Yang Li1, Yuan-Yuan Wang1, Juan Feng1, Qiu-Yan He1, Shan-Shan Lu1, Zhi-Qiang Xiao2.   

Abstract

Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment, but little is known about how miRNA (miR) regulates this phenomenon. In this study, we investigated the function and mechanism of miR-203 in NPC radioresistance, one of downregulated miRs in the radioresistant NPC cells identified by our previous microarray analysis. We observed that miR-203 was frequently downregulated in the radioresistant NPC tissues compared with radiosensitive NPC tissues, and its decrement significantly correlated with NPC radioresistance and poor patient survival, and was an independent predictor for reduced patient survival. In vitro radioresponse assays showed that miR-203 mimic markedly decreased NPC cell radioresistance. In a mouse model, therapeutic administration of miR-203 agomir dramatically sensitized NPC xenografts to irradiation. Mechanistically, we confirmed that IL8 was a direct target of miR-203, and found that reduced miR-203 promoted NPC cell radioresistance by activating IL8/AKT signaling. Moreover, the levels of IL8 and phospho-AKT were significantly increased in the radioresistant NPC tissues compared with radiosensitive NPC tissues, and negatively associated with miR-203 level. Our data demonstrate that miR-203 is a critical determinant of NPC radioresponse, and its decrement enhances NPC radioresistance through targeting IL8/AKT signaling, highlighting the therapeutic potential of the miR-203/IL8/AKT signaling axis in NPC radiosensitization. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26304234     DOI: 10.1158/1535-7163.MCT-15-0461

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  46 in total

1.  Noncoding RNAs in inflammation and colorectal cancer.

Authors:  Shengyun Ma; Tianyun Long; Wendy Jia Men Huang
Journal:  RNA Biol       Date:  2019-12-26       Impact factor: 4.652

Review 2.  Autophagy-regulating microRNAs: potential targets for improving radiotherapy.

Authors:  Hongbin Li; Xiaodong Jin; Bing Chen; Ping Li; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-03       Impact factor: 4.553

3.  MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.

Authors:  Zhao Xiaohong; Fan Lichun; Xie Na; Zou Kejian; Xiao Xiaolan; Wang Shaosheng
Journal:  Tumour Biol       Date:  2016-09-21

4.  MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.

Authors:  Anmin You; Liwu Fu; Yongjiao Li; Xingyi Li; Bin You
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

5.  CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.

Authors:  Nicolas Goffart; Arnaud Lombard; François Lallemand; Jérôme Kroonen; Jessica Nassen; Emmanuel Di Valentin; Sharon Berendsen; Matthias Dedobbeleer; Estelle Willems; Pierre Robe; Vincent Bours; Didier Martin; Philippe Martinive; Pierre Maquet; Bernard Rogister
Journal:  Neuro Oncol       Date:  2016-07-01       Impact factor: 12.300

6.  MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.

Authors:  Chartia Ching-Mei Cheung; Samantha Wei-Man Lun; Grace Tin-Yun Chung; Chit Chow; Carman Lo; Kwong-Wai Choy; Kwok-Wai Lo
Journal:  BMC Cancer       Date:  2016-07-19       Impact factor: 4.430

7.  MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.

Authors:  Shao-Jun Chu; Ge Wang; Peng-Fei Zhang; Rui Zhang; Yan-Xia Huang; Yun-Min Lu; Wei Da; Qun Sun; Jing Zhang; Jin-Shui Zhu
Journal:  J Exp Clin Cancer Res       Date:  2016-03-15

8.  Time-course differential lncRNA and mRNA expressions in radioresistant hypopharyngeal cancer cells.

Authors:  Jieyu Zhou; Shengda Cao; Wenming Li; Dongmin Wei; Zhentao Wang; Guojun Li; Xinliang Pan; Dapeng Lei
Journal:  Oncotarget       Date:  2017-06-20

9.  Investigation of miR-93-5p and its effect on the radiosensitivity of breast cancer.

Authors:  Chi Pan; Guangzhi Sun; Min Sha; Peng Wang; Yawen Gu; Qingtao Ni
Journal:  Cell Cycle       Date:  2021-05-24       Impact factor: 4.534

Review 10.  DNA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance.

Authors:  Lucia Centurione; Francesca B Aiello
Journal:  Front Oncol       Date:  2016-07-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.